用阿糖胞苷或环磷酰胺对L1210白血病小鼠进行时辰化疗。 - Suppr | 超能文献

Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.

作者信息

Rose W C, Trader M W, Laster W R, Schabel F M

出版信息

Cancer Treat Rep. 1978 Sep;62(9):1337-49.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.用阿糖胞苷或环磷酰胺对L1210白血病小鼠进行时辰化疗。

Cancer Treat Rep. 1978 Sep;62(9):1337-49.

2

Chronochemotherapy: L 1210 leukemia and beyond.时辰化疗：L1210白血病及其他。

Chronobiologia. 1979 Jul-Sep;6(3):203-11.

3

Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.不同剂量的甲氨蝶呤（NSC - 740）、阿糖胞苷（NSC - 63878）和环磷酰胺（NSC - 26271）对L1210白血病小鼠耐药性的影响。

Cancer Chemother Rep. 1972 Aug;56(4):473-81.

4

Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-beta-D-arabinofuranosylcytosine.环磷酰胺和1-β-D-阿拉伯呋喃糖基胞嘧啶治疗的昼夜节律优化后白血病小鼠的存活与治愈

Cancer Res. 1977 Oct;37(10):3648-55.

5

Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.用环磷酰胺（NSC - 26271）和阿糖胞苷（NSC - 63878）对患有晚期白血病L1210的小鼠进行序贯化疗。

Cancer Chemother Rep. 1969 Oct;53(5):265-71.

6

Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.使用1-β-D-阿拉伯呋喃糖基胞嘧啶、环磷酰胺、长春新碱、甲泼尼龙和顺二氯二氨铂对L1210白血病小鼠进行联合时辰化疗。

Chronobiologia. 1980 Jan-Mar;7(1):33-40.

7

Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.使用1-β-D-阿拉伯呋喃糖基胞嘧啶、环磷酰胺、长春新碱和甲基泼尼松龙对L1210白血病进行治疗的昼夜节律优化。

Chronobiologia. 1980 Jan-Mar;7(1):41-51.

8

A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).一种肿瘤生长与化疗的计算机模型及其在阿糖胞苷（NSC - 63878）治疗L1210白血病中的应用。

Cancer Chemother Rep. 1970 Dec;54(6):399-429.

9

Single versus combination chemotherapy of L1210 leukemia.L1210白血病的单药化疗与联合化疗

Neoplasma. 1980;27(6):691-6.

10

[Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].[用脱氧胞苷与致死剂量阿糖胞苷联合对白血病L1210进行选择性治疗]

Biull Eksp Biol Med. 1978 Mar;85(3):340-3.

引用本文的文献

1

Cancer chronomics I. Origins of timed cancer treatment: early marker rhythm-guided individualized chronochemotherapy.癌症时间组学I. 定时癌症治疗的起源：早期标志物节律引导的个体化时辰化疗

J Exp Ther Oncol. 2006;6(1):55-61.

2

Transdisciplinary unifying implications of circadian findings in the 1950s.20世纪50年代昼夜节律研究结果的跨学科统一影响。

J Circadian Rhythms. 2003 Oct 29;1(1):2. doi: 10.1186/1740-3391-1-2.

3

Diurnal variations of tumor growth and its influence on cytostatic treatment.肿瘤生长的昼夜变化及其对细胞抑制治疗的影响。

Blut. 1981 Aug;43(2):85-8. doi: 10.1007/BF00320465.